China cultivated meat firm CellX has revealed both its short-term and long-term strategies to bring its novel products to the commercialisation stage, with plans to build its own facility some time in 2023 to facilitate its focus on cost reduction and scaling up.
April 6, 2022
This clipping was added via the Protein Report NewsEngine, a market intelligence tool for tracking developments in the protein industries. Learn more.
In This Article
Hong Kong SAR China 2014
China 2020
